ImmunoScope uses T cell receptor (TCR) analysis to enhance outcomes of bone marrow transplants.

We are developing the first predictive, pre-transplant TCR tests - the Novel and Tolerant Fraction tests - for pre-transplant use by applying our proprietary algorithm and utilizing patient datasets with matched clinical outcomes data.

Built with clinical samples paired with real-world outcomes, our differentiated approach allows us to generate orthogonal insights into bone marrow transplant biology and enhance the established pre-transplant diagnostic workup and inform clinical decision making before, during, and immediately following transplant.

Our mission is to provide transplant physicians with actionable intelligence improving transplant outcomes through more precise donor selection and treatment decisions, and safer, more personalized care grounded in biological truth.